Polyrizon Ltd.

PLRZ Healthcare Biotechnology

10.00 0.01 −0.10%
Market cap
$23.7M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '22 Dec '23 Dec '24 Dec '25
Current Ratio
0.04 0.11 10.16 29.03
Net Debt/EBITDA
0.04 (0.25) 2.16 2.11
Debt/Equity
0.00 (1.05) 0.00 0.00
ROE
0.00% 109.99% (60.65%) (25.38%)
ROA
0.00% (108.60%) (50.61%) (24.72%)
ROIC
0.00% 0.00% (29.79%) (45.79%)
Return on Tangible Assets
68.88% 137.61% (64.32%) (26.83%)
Free Cash Flow per Share
(1,261.11) (383.57) (573.50) (6.67)
Book value per Share
(1,000.00) (136.43) 2,643.00 30.86
Free Cash Flow
(1.13) (0.54) (1.15) (4.53)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 30 Sep 2026